news, journals and articles from all over the world.
The most recent data available suggests reported cases of sexually transmitted diseases (STDs) have declined. This is good news, but experts at University of California San Diego AntiViral Research Center say STD rates could soon be on the rise again.…
UC San Diego researchers discovered that patient survival from sepsis is associated with higher platelet counts, and identified two currently available drugs that protect these blood cells and improve survival in mice with sepsis.
Investigators from UC San Diego and UCLA report COVID-19 infection rates for a cohort of health care workers previously vaccinated for the novel coronavirus. Risk of infection is minuscule, but exists.
A new research study at the University of Chicago Medicine has found that when it comes to COVID-19, having vitamin D levels above those traditionally considered sufficient may lower the risk of infection, especially for Black people.
Using molecular dating tools and epidemiological simulations, researchers at UC San Diego School of Medicine estimate that the SARS-CoV-2 virus likely circulated undetected for two months before the first human cases of COVID-19 were described in Wuhan, China in late-December 2019.
A Michigan Medicine team’s online guidelines have been viewed more than 30,000 times by providers in 150 countries since the beginning of the pandemic–and their deployment of an effective COVID-19 therapy has been a model for health systems and hospitals statewide.
Nursing homes with the largest proportions of non-White residents experience 3.3 times more COVID-19 deaths than do nursing homes with the largest proportions of White residents, according to a new study from the University of Chicago.
UC San Diego School of Medicine researchers develop an automated process to test city sewage for SARS-CoV-2, allowing them to forecast the region’s COVID-19 caseload one to two weeks ahead of clinical diagnostic reports.
A repurposed drug used to treat arthritis did not significantly improve the outcomes of patients with severe COVID-19 pneumonia. Tocilizumab did not significantly improve clinical status or mortality rate at 28 days for participants who received it compared to a placebo.
UC San Diego was awarded five COVID-19 Rapid Acceleration of Diagnostics (RADx) projects by the National Institutes of Health totaling nearly $33 million, which will fund efforts that range from managing a large data center to expanding testing in disadvantaged communities.
There is now keen interest in deeper investigation of infectious agents as the trigger of Alzheimer’s disease
UC San Diego researchers report that individual immune response to SARS-CoV-2 may be limited by a set of variable genes that code for cell surface proteins essential for the adaptive immune system. The finding may help explain why COVID-19 immunity varies by individual.
University of Miami Miller School of Medicine researchers are recruiting health care workers to study whether a wearable device, a wristwatch, can capture real time data that can be used to alert wearers of subtle physiological changes that may indicate they have become infected with COVID-19.
In an effort to help schools reduce the risk of COVID-19 outbreaks as they resume in-person instruction, UC San Diego and the County of San Diego are testing the Safer at School Early Alert system to detect SARS-CoV-2 at schools and child care centers.
Rush University Medical Center is opening an advanced molecular laboratory that will examine COVID-19 samples from across the city to detect new strains of the virus for the Chicago Department of Public Health
The National Italian American Foundation (NIAF) is now accepting applications for the inaugural class of Fauci Fellowships, created in recognition of Dr. Anthony S. Fauci’s contributions to humanity and the medical and scientific community.
UC San Diego researchers find that an optical tool already embedded in many smartphones can accurately diagnose blood-oxygen levels and help monitor respiratory disease in patients, particularly when they are quarantined at home.
The 2019-2020 flu season in the U.S. was unusual in a number of ways. Cases picked up in August rather than the more typical fall and early winter months, and it hit children particularly hard.
Cedars-Sinai has launched the COVID-19 Recovery Program to meet the needs of a growing number of COVID-19 patients who experience lingering symptoms weeks and even months after physicians say they are virus-free.
CLEVELAND: As part of the new Cleveland Innovation District announced today by State of Ohio Governor Mike DeWine, Lieutenant Governor Jon Husted, JobsOhio and Ohio Development Services Agency, Cleveland Clinic will significantly expand its global commitment to infectious disease research and translational programs to form the Global Center for Pathogen Research & Human Health.
The new Center will position Ohio as an international leader for research into emerging pathogens and virus-related diseases and will serve as a significant economic catalyst in Northeast Ohio. Funding comes through a $500 million investment from the State of Ohio, JobsOhio and Cleveland Clinic.
Even as vaccinations against COVID-19 are under way, the virus continues to kill thousands of Americans every day, making it more important than ever to stay safe and be ready in case it strikes you or your family. Here’s what you need to do to prevent and prepare for the novel coronavirus.
Wildfire smoke contains microbes, infectious agents that might cause diseases. In a perspective piece published in Science, researchers at UC Davis Health and the University of Idaho proposed a multidisciplinary approach to study the health impacts of microbes carried by wildfire smokes.
Moderate temperature increases broke down SARS-CoV-2 virus-like particles structure on glass surfaces, suggesting that virus particles on surfaces will remain infectious longer. The findings agree with observations of other coronaviruses that appear to infect more people during the winter.
Hospital-based laboratories and doctors at the front line of the COVID-19 pandemic might soon add artificial intelligence to their testing toolkit. A recent study describes the performance of Biocogniv’s new AI-COVID™ software, which showed high accuracy in predicting the probability of COVID-19 infection using routine blood tests, which can help hospitals reduce the number of patients referred for scarce PCR testing.
Public health experts predict the United States may be headed for thousands of new COVID-19 cases and deaths this winter, a surge that is already straining health care systems around the country. The George Washington University has the following experts…
Researchers at Children’s Hospital of Philadelphia (CHOP) have found elevated levels of a biomarker related to blood vessel damage in children with SARS-CoV-2 infection, even if the children had minimal or no symptoms of COVID-19. They also found that a high proportion of children with SARS-CoV-2 infection met clinical and diagnostic criteria for thrombotic microangiopathy (TMA). TMA is a syndrome that involves clotting in the small blood vessels and has been identified as a potential cause for severe manifestations of COVID-19 in adults.
The California governor’s office today announced a statewide expansion to make CA Notify available to all Californians starting Thursday, December 10 in partnership with UC San Diego Health.
SEATTLE – Dec. 2, 2020 – Below are summaries of recent Fred Hutch research findings and other news with links for additional background and media contacts.If you’re following the American Society of Hematology’s annual meeting (virtual, Dec. 5-8), see our media tip sheet highlighting Fred Hutch presentations and activities, including those by current ASH president Dr.
University of California San Diego has been selected by the NIH to lead and administer an international seven-year, $28-million grant for HIV/AIDS clinical trials.
New evidence-based clinical practice guidelines for the prevention, diagnosis, and treatment of Lyme disease have been developed by a multidisciplinary panel led by the Infectious Diseases Society of America, the American Academy of Neurology, and the American College of Rheumatology. Representatives from an additional 12 medical specialties and patients also served on the panel.
Most media and public attention during the pandemic has focused upon efforts to develop an effective vaccine to prevent COVID-19, which is caused by the novel coronavirus SARS-CoV-2. Some attention has been paid to investigational therapeutics for treating infected patients,…
While respiratory issues continue to be the most common symptom of a COVID-19 infection, new research indicates the disease could also be associated with an increased tendency of the blood to clot, leading to a higher risk of death from COVID-19.
UNLV researcher Edwin Oh and colleagues have implemented wastewater surveillance programs to screen samples for the presence of COVID-19 and to extract the RNA from the SARS-COV-2 virus to find targets that make vaccines more effective.
A group of vaccine experts led by Children’s Hospital of Philadelphia (CHOP) has published recommendations to ensure equitable distribution of a COVID-19 vaccine when it becomes available. The framework, published today in Heath Affairs, focuses on five principles the authors believe would strengthen the current immunization delivery system to ensure equitable access to everyone for whom vaccination is recommended.
Throughout the COVID-19 pandemic, Rush University Medical Center has been a leader in the Chicago area in developing, expanding and evolving testing efforts. On Friday, Nov. 13, the Medical Center performed its 100,000th test for COVID-19.
A team of American and Canadian researchers report that while they may feel uncomfortable, there is little empirical evidence that wearing a facemask significantly diminishes lung function, even when worn during heavy exercise.
The heart of inpatient care for psychiatric patients is socialization, group therapy and shared meals. Then COVID-19 hit with the public health warnings to isolate, socially distance, and wear masks. UTHealth had to figure out how to ride that line.
The virus that causes COVID-19 was present in New York City long before the city’s first case of the disease was confirmed on March 1
A team from Seattle Children’s Research Institute has developed an improved mouse model for tuberculosis that replicates characteristics of the human disease not possible in other available models. The ultra-low dose model, named that because mice are infected with 1-3…
Researchers determined that COVID-19 transmission risk via Halloween candies is low, even when they are handled by infected people, but handwashing and disinfecting collected sweets reduces risk even further.
Researchers have found that a more intensive, less frequent drug regimen with currently available therapeutics could cure the infection that causes Chagas disease
Families gathered around the table for hours to share food, conversation and laughter — all the ingredients for a joyous holiday — and the spread of COVID-19. Rush infectious disease specialists and a child psychologist share facts and tips for enjoying the holidays safely.
Since its inception in 1995, the mission for A Woman’s Journey has remained the same: to empower women to make the right health care decisions for their families and themselves.
Johns Hopkins Medicine has launched a new Spanish-language COVID-19 resources portal. This one-stop shop for information in Spanish offers COVID-19 testing sites, information about telemedicine and communicating with health care providers, social distancing tips and resources for children, among other helpful links. The mobile-friendly portal serves community members, patients, faculty and staff members as well as students who need COVID-19 resources and information in Spanish.
Treatment with a peptide that mimics the naturally occurring protein GIV prevents immune overreaction and supports a mechanism critical for survival in mouse models of sepsis and colitis, according to a UC San Diego study.
New research in Clinical and Translational Immunology, provides a clearer picture of the protective antibodies induced by SARS-CoV-2 and their role in serious illness and what’s needed for full protection.
Accomplishing a feat that had been a pipe dream for decades, scientists at University of Utah Health and University of Virginia have recreated in a test tube the first steps of infection by HIV (human immunodeficiency virus), the virus that causes AIDS (acquired immunodeficiency syndrome). Doing so has provided up-close access to the virus—which is otherwise obstructed from view deep within the cell—and enabled identification of essential components that HIV needs to replicate within its human host. The research publishes in the journal, Cell.
Johns Hopkins Medicine biomedical engineering student Christopher Shallal developed an initiative to keep health care teams safe by galvanizing community members to use 3D printers to make face shields. His mentors on the project were Elizabeth Logsdon, Ph.D., and Warren Grayson, Ph.D.
In a new study, infectious disease researchers show that HIV viremia isn’t always nonadherence to medication or resistance to the drugs. Instead, the patients are victims of what the scientists have dubbed “repliclones” – large clones of HIV-infected cells that produce infectious virus particles.
The Chicago Center for HIV Elimination, housed at the University of Chicago, has been awarded $5 million over two years through the National Institute of Health’s (NIH) RADx Underserved Populations program to support a COVID-19 testing project to engage two disenfranchised populations.
English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
Urdu